UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial

Scientific reports, 2024-10, Vol.14 (1), p.25028-9, Article 25028

2024

Volltextzugriff (PDF)

Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)

Trials, 2020-10, Vol.21 (1), p.846-3, Article 846

2020

Volltextzugriff (PDF)

Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment

Journal of acquired immune deficiency syndromes (1999), 2015-02, Vol.68 (2), p.204-208

2015

Volltextzugriff (PDF)

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study

Vaccine, 2008-05, Vol.26 (21), p.2657-2666

2008

Volltextzugriff (PDF)

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Clinical infectious diseases, 2006-06, Vol.42 (12), p.1790-1799

2006

Volltextzugriff (PDF)

Performance of four centralized statistical monitoring methods for early detection of an atypical center in a multicenter study

Contemporary clinical trials communications, 2023-08, Vol.34, p.101168-101168, Article 101168

2023

Volltextzugriff (PDF)

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study

Contemporary clinical trials, 2011-01, Vol.32 (1), p.16-24

2011

Volltextzugriff (PDF)

Therapeutic Patient Education for Fibromyalgia during Spa Therapy: The FiETT Randomized Controlled Trial

International journal of environmental research and public health, 2022-04, Vol.19 (8), p.4613

2022

Volltextzugriff (PDF)

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

The New England journal of medicine, 2015-08, Vol.373 (9), p.808-822

2015

Volltextzugriff (PDF)

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

The American journal of tropical medicine and hygiene, 2015-08, Vol.93 (2), p.300-304

2015

Volltextzugriff (PDF)

Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy

Clinical infectious diseases, 2004-07, Vol.39 (2), p.248-255

2004

Volltextzugriff (PDF)

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)

Journal of antimicrobial chemotherapy, 2011, Vol.66 (1), p.184-191

2011

Volltextzugriff (PDF)

Public clinical trials: which kind of monitoring should be used?

Therapie, 2013-05, Vol.68 (3), p.135-141

2013

Volltextzugriff (PDF)

A new centralized statistical monitoring method for detecting atypical distribution of qualitative variables in multicenter randomized controlled trials

Statistics in biopharmaceutical research, 2024-09, p.1-14

2024

Volltextzugriff (PDF)

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

The Lancet global health, 2017-11, Vol.5 (11), p.e1080-e1089

2017

Volltextzugriff (PDF)

Remote preenrollment checking of consent forms to reduce nonconformity

Clinical trials (London, England), 2013-06, Vol.10 (3), p.449-459

2013

Volltextzugriff (PDF)

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients

Journal of acquired immune deficiency syndromes (1999), 2003-12, Vol.34 (5), p.497-499

2003

Volltextzugriff (PDF)

Preserving participant anonymity during remote preenrollment consent form checking

Clinical trials (London, England), 2013-06, Vol.10 (3), p.460-462

2013

Volltextzugriff (PDF)

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial)

Antiviral therapy, 2007-01, Vol.12 (3), p.417-422

2007

Volltextzugriff (PDF)

The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort

Journal of acquired immune deficiency syndromes (1999), 2001-11, Vol.28 (3), p.232-239

2001

Volltextzugriff (PDF)

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso

PloS one, 2014-10, Vol.9 (10), p.e111240-e111240

2014

Volltextzugriff (PDF)

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

The Journal of infectious diseases, 2005-03, Vol.191 (6), p.830-839

2005

Volltextzugriff (PDF)

PMTCT care cascade and factors associated with attrition in the first four years after Option B+ implementation in Mozambique

Tropical medicine & international health, 2020-02, Vol.25 (2), p.222-235

2020

Volltextzugriff (PDF)

Missed opportunities of inclusion in a cohort of HIV‐infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013

Journal of the International AIDS Society, 2016-01, Vol.19 (1), p.20601-n/a

2016

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)

Sprache

Englisch
(42)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Atorvastatin and telmisartan do not reduce nasopharyngeal carriage of SARS-CoV-2 in mild or moderate COVID-19 in a phase IIb randomized controlled trial

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Performance of four centralized statistical monitoring methods for early detection of an atypical center in a multicenter study

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study

Therapeutic Patient Education for Fibromyalgia during Spa Therapy: The FiETT Randomized Controlled Trial

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability

Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)

Public clinical trials: which kind of monitoring should be used?

A new centralized statistical monitoring method for detecting atypical distribution of qualitative variables in multicenter randomized controlled trials

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

Remote preenrollment checking of consent forms to reduce nonconformity

Plasma levels of indinavir and nelfinavir at time of virologic response may have a different impact on the risk of further virologic failure in HIV-infected patients

Preserving participant anonymity during remote preenrollment consent form checking

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial)

The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort

Missed opportunities for early access to care of HIV-infected infants in Burkina Faso

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

PMTCT care cascade and factors associated with attrition in the first four years after Option B+ implementation in Mozambique

Missed opportunities of inclusion in a cohort of HIV‐infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013

Suchergebnisse filtern